Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$9.95 - $12.27 $134,325 - $165,645
-13,500 Reduced 54.34%
11,343 $119,000
Q1 2022

Apr 18, 2022

SELL
$9.81 - $15.4 $42,918 - $67,375
-4,375 Reduced 14.97%
24,843 $270,000
Q4 2021

Jan 19, 2022

SELL
$12.09 - $14.68 $51,358 - $62,360
-4,248 Reduced 12.69%
29,218 $395,000
Q3 2021

Oct 26, 2021

BUY
$13.25 - $15.13 $47,488 - $54,225
3,584 Added 11.99%
33,466 $453,000
Q2 2021

Jul 20, 2021

BUY
$12.97 - $16.15 $99,817 - $124,290
7,696 Added 34.69%
29,882 $427,000
Q1 2021

Apr 22, 2021

BUY
$13.59 - $18.54 $301,507 - $411,328
22,186 New
22,186 $310,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.